Completed NA INTERVENTIONAL 1-arm NCT01392872

Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant (CoQualSEP)

Evaluation of Cognitive Disability and Quality of Life of Patients Suffering From Multiple Scleroses and Treat With Immunosuppressant

Sponsor: Dr Remy MORELLO - CHU de Caen

Conditions Multiple Sclerosis, Relapsing-Remitting

Interventions Neuropsychological assessment

Updated 6 times since 2017 Last updated: Jul 28, 2016 Started: Nov 30, 2009 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01392872, this NA trial focuses on Multiple Sclerosis, Relapsing-Remitting and remains completed. Sponsored by Dr Remy MORELLO - CHU de Caen, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Sep 2020 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr Remy MORELLO - CHU de Caen
University Hospital, Bordeaux
University Hospital, Caen
University Hospital, Clermont-Ferrand
University Hospital, Marseille

Data source: University Hospital, Clermont-Ferrand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clermont-Ferrand, France